BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 16891678)

  • 1. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
    Bajpai A; Kabra M; Gupta AK; Menon PS
    Indian Pediatr; 2006 Jul; 43(7):593-9. PubMed ID: 16891678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
    Korpal-Szczyrska M; Dorant B; Kamińska H; Birkholz D; Niedźwiecki M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
    Seminara S; Stagi S; Candura L; Scrivano M; Lenzi L; Nanni L; Pagliai F; Chiarelli F
    Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
    Giovenale D; Meazza C; Cardinale GM; Farinelli E; Mastrangelo C; Messini B; Citro G; Del Vecchio M; Di Maio S; Possenti I; Bozzola M
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
    Rachmiel M; Rota V; Atenafu E; Daneman D; Hamilton J
    Horm Res; 2007; 68(5):236-43. PubMed ID: 17396034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.
    Boot AM; van der Sluis IM; Krenning EP; de Muinck Keizer-Schrama SM
    Horm Res; 2009; 71(6):364-71. PubMed ID: 19506395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
    Trollmann R; Bakker B; Lundberg M; Doerr HG
    Pediatr Rehabil; 2006; 9(2):144-8. PubMed ID: 16449073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II).
    Binder G; Iliev DI; Mullis PE; Ranke MB
    Growth Horm IGF Res; 2007 Jun; 17(3):242-8. PubMed ID: 17360215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
    Wit JM; Rekers-Mombarg LT; Cutler GB; Crowe B; Beck TJ; Roberts K; Gill A; Chaussain JL; Frisch H; Yturriaga R; Attanasio AF
    J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Growth follow-up of SGA children after 3 years of GH treatment].
    Edouard T; Oliver I; Jouret B; Lounis N; Moulin P; Pienkowski C; Elefterion M; Salles JP; Tauber M
    Arch Pediatr; 2008 Feb; 15(2):115-21. PubMed ID: 18207714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
    Ranke MB; Guilbaud O
    Acta Paediatr Scand Suppl; 1991; 379():109-15; discussion 116. PubMed ID: 1815451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The model of height prognosis in children with growth hormone deficiency].
    Kostecka L; Wasikowa R; Noczyńska A; Filipowski H
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):113-7. PubMed ID: 15504314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height outcome of growth hormone-deficient patients treated since less than five years of age.
    De Luca F; Maghnie M; Arrigo T; Lombardo F; Messina MF; Bernasconi S
    Acta Paediatr; 1996 Oct; 85(10):1167-71. PubMed ID: 8922077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hypophyseal dwarfism with biosynthetic growth hormone].
    Blümel P; Stögmann W
    Wien Klin Wochenschr; 1989 Dec; 101(24):861-3. PubMed ID: 2623878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.